Option Chain

Bicara Therapeutics Inc

BCAXNASDAQ · USD

22.64USD0.00 (+0.23%)

2310

Bicara Therapeutics Inc (BCAX) Option Chain

As of September 18, 2026, Bicara Therapeutics Inc is trading at $22.64, a +0.23% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 61.2%. IV Rank is 11%.

Tracking the BCAX option chain helps you see every strike and expiry on Bicara Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Bicara Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BCAX options activity at a glance. Use our scanner to monitor the BCAX option chain in real time and filter for the BCAX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BCAX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the BCAX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where BCAX stock options are being actively traded and where they are not.

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Bicara Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen BCAX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of BCAX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile7.14% Subdued
Market cap (M$)1,498
52 weeks high-26.94%
52 weeks low119.81%
Analyst recommendationStrong Buy
1.29
Target price$33.92
49.82% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-09
P/E—
Future P/E—
EPS (ttm)-3.09
EPS growth next 5 years-9.84%

As of September 18, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
6.98	0	0	0.36	5.14	3.50	7.50	17.50	-22.70	—	4.90	0.00	4.90	0	0	93.02
24.92	0	0	0.61	2.64	1.00	5.50	20.00	-11.66	—	2.90	0.00	2.90	0	0	75.08
51.14	3	0	4.76	0.14	—	4.90	22.50	-0.62	—	4.90	0.00	4.90	0	0	48.86
74.53	100	0	4.90	0.00	—	4.90	25.00	+10.42	0.70	4.90	2.36	0.44	0	5	25.47
96.01	3	0	4.90	0.00	—	4.90	30.00	+32.51	5.00	9.50	7.36	-0.11	0	1	3.99

As of September 18, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place